3Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [ J ] . Catheter Cardiovasc Interv,2013,82 (4) : E266 -355.
4Montalescot G, Cohen M, Salette G, et al. Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention : insights from the STEEPLE trial [ J ]. Eur Heart J,2008,29(4) :462-471.
5Chew DP, Bhatt DL, Lincoff AM, et al. Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials [J]. Circulation ,2001,103 (7) :961-966.
6Brener SJ, Moliterno D J, Lincoff AM, et al. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention [J]. Circulation, 2004,110 ( 8 ) : 994 -998.
7Hillegass WB, Brott BC, Chapman GD,et al. Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications [J]. Am Heart J, 2002, 144 (3) :501-507.
8Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention) [ J] . Circulation, 2006, 113 (7) : e166- 286.
9O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardialinfarction : executive summary : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [ J ]. J Am Coll Cardiol, 2013,61 ( 4 ) : 485- 510.
10Montalescot G, White HD, Gallo R, et al. Enoxaparin versus unfraetionated heparin in elective percutaneous coronary intervention[ J]. N Engl J Med,2006,355 (10) :1006-1017.
